Word

OZETTE

Status

Pending

Status Code

730

Status Date

Friday, March 22, 2024

Serial Number

97374157

Mark Type

4000

Filing Date

Thursday, April 21, 2022

Published for Opposition

Tuesday, June 27, 2023

Trademark Owner History

Ozette Technologies, Inc. - Owner At Publication

Classifications

9 Downloadable computer software using artificial intelligence (AI) and machine learning for analysis of immune data for the purposes of medical research, diagnosis, and treatment; downloadable computer software using artificial intelligence (AI) and machine learning for analysis of immune data for the purposes of identifying, prescribing, and monitoring medications; downloadable computer software using artificial intelligence (AI) and machine learning for diagnosing, monitoring, and treating diseases and disorders, namely, infectious disease, cancer, autoimmune disorders, cardiovascular disease, and neurological disorders; software as a Medical Device (SaMD), downloadable, for analyzing the immune system for the purposes of medical diagnosis and treatment; software as a Medical Device (SaMD), downloadable, for analyzing the immune system for the purposes of identifying, prescribing and monitoring medications; software as a Medical Device (SaMD), downloadable, for diagnosing, monitoring and treating diseases and disorders, namely, infectious disease, cancer, autoimmune disorders, cardiovascular disease, and neurological disorders; computer hardware; computer hardware with imbedded software for diagnosing, monitoring, and treating diseases and disorders, namely, infectious disease, cancer, autoimmune disorders, cardiovascular disease, and neurological disorders; research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids

5 Medical diagnostic reagents and assays for testing and analyzing blood and other bodily fluids; diagnostic kits comprised of medical diagnostic reagents and assays for testing of blood and other bodily fluids for use in disease and disorder detection, namely, infectious disease, cancer, autoimmune disorders, cardiovascular disease, and neurological disorders; pharmaceutical preparations for use in treating infectious disease, cancer, autoimmune disorders, cardiovascular disease, and neurological disorders; drug testing kits comprised of medical diagnostic reagents and assays for testing blood and other bodily fluids; diagnostic reagents for medicinal use

1 Chemical test kits for diagnosing, monitoring, and treating infectious disease, cancer, autoimmune disorders, cardiovascular disease, and neurological disorders for laboratory or research use; assays for research purposes; assays for testing blood and other bodily fluids for research purposes; assays and reagents for use in infectious disease, oncology, autoimmunity, cardiovascular, and neurological disorders research

10 Medical device for detecting diseases and disorders, namely, infectious disease, cancer, autoimmune disorders, cardiovascular disease, and neurological disorders; medical device, namely, medical device for disease and disorder diagnosis, monitoring of biological material and cell populations, and medical treatment device in the nature of medical devices for the interrogation of biological samples; medical devices for detection and treatment of infectious disease, cancer, autoimmune disorders, cardiovascular disease, and neurological disorders; apparatus for blood analysis; apparatus for taking blood samples; blood collection kit comprised of medical tubes and vials, tube and vial holders, and transportation device and blood testing apparatus; medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of infectious disease, oncology, autoimmunity, cardiovascular, and neurological disorders; laboratory apparatus, namely, diagnostic apparatus for the interrogation of biological samples featuring artificial intelligence (AI) and machine learning recorded software for medical diagnosis, monitoring, and treatment of diseases and disorders, namely, infectious disease, cancer, autoimmune disorders, cardiovascular disease, and neurological disorders; laboratory apparatus, namely, diagnostic apparatus for the interrogation of biological samples featuring artificial intelligence (AI) and machine learning recorded software for monitoring the immune system for the purposes of identifying, prescribing, and monitoring medications; laboratory apparatus and instruments in the nature of medical devices and diagnostic apparatus for the interrogation of biological samples for diagnosing diseases and disorders, namely, infectious disease, cancer, autoimmune disorders, cardiovascular disease, and neurological disorders

Trademark Events

Mar 23, 2024

Notice Of Approval Of Extension Request E-Mailed

Mar 23, 2024

Corrected Noa E-Mailed

Mar 22, 2024

Divisional Processing Complete

Feb 6, 2024

Divisional Request Received

Mar 22, 2024

Sou Extension 1 Granted

Feb 5, 2024

Sou Extension 1 Filed

Feb 6, 2024

Teas Request To Divide Received

Feb 29, 2024

Case Assigned To Intent To Use Paralegal

Feb 5, 2024

Sou Teas Extension Received

Aug 22, 2023

Noa E-Mailed - Sou Required From Applicant

Jun 27, 2023

Official Gazette Publication Confirmation E-Mailed

Jun 27, 2023

Published For Opposition

Jun 7, 2023

Notification Of Notice Of Publication E-Mailed

May 25, 2023

Approved For Pub - Principal Register

May 25, 2023

Examiner's Amendment Entered

May 25, 2023

Notification Of Examiners Amendment E-Mailed

May 25, 2023

Examiners Amendment E-Mailed

May 25, 2023

Examiners Amendment -Written

May 24, 2023

Teas/Email Correspondence Entered

May 22, 2023

Correspondence Received In Law Office

May 22, 2023

Teas Response To Office Action Received

Feb 23, 2023

Notification Of Non-Final Action E-Mailed

Feb 23, 2023

Non-Final Action E-Mailed

Feb 23, 2023

Non-Final Action Written

Feb 8, 2023

Assigned To Examiner

Apr 27, 2022

New Application Office Supplied Data Entered

Apr 25, 2022

New Application Entered